港股异动丨一脉阳光3日连升累涨超11% 获若干董事增持总计9.65万股

Core Viewpoint - The stock of Yipai Yangguang (2522.HK) has experienced a significant increase, rising over 11% in the last three trading days, driven by insider buying and positive developments in its business sectors [1] Group 1: Stock Performance - Yipai Yangguang's stock opened high today, reaching a peak increase of 4.4% to HKD 16.62 [1] - The stock has seen a cumulative rise of over 11% over the past three trading days [1] Group 2: Insider Buying - Company directors, including the Chairman and CEO Chen Chaoyang, purchased a total of 96,500 shares of the company's H-shares using personal funds on November 3 and 4, 2025 [1] - The decision for this increase in shareholding is based on the directors' confidence in the company's recent achievements in regional medical imaging sharing centers and data services [1] Group 3: Business Development and Strategic Alignment - The company has demonstrated strong capabilities in the "data + AI/algorithm + application scenario" full industry chain of smart medical imaging, which has been positively recognized [1] - The company's strategic layout in innovation aligns well with the State Council's implementation opinions on promoting and regulating the application of "AI + healthcare" issued on November 4, 2025 [1] - Directors believe that the current H-share price does not fully reflect the long-term investment value of the company [1]